» Articles » PMID: 35303020

Prevalence of Low Vitamin D Levels in Patients with Hidradenitis Suppurativa in Jordan: A Comparative Cross-sectional Study

Overview
Journal PLoS One
Date 2022 Mar 18
PMID 35303020
Authors
Affiliations
Soon will be listed here.
Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the apocrine gland bearing skin, presenting various stages of flexural skin pain, erythema, painful nodules, abscesses, sinuses, and fistulas. We aimed to assess serum vitamin D levels in patients with (HS) in Jordan. a cross-sectional comparative study conducted among 110 patients with HS and 110 matched controls, who didn't previously receive vitamin D therapy. Serum vitamin D was measured and classified into normal (>30 ng/ml), insufficient (20-30 ng/ml), and low (<20 ng/ml). The mean age of the cases was 43.1 ± 12.9 years and the mean disease duration was 19.4 months. The mean body mass index among patients with HS was 30 and about 34% of them were smokers. The mean Vitamin D level was 8.4 ng/ml and all HS patients were vitamin D deficient. Patients of HS were more likely to have vitamin D deficiency compared to healthy controls. Most of the study subjects and particularly all of the patients with HS have low vitamin D levels. Smoking and high BMI, were associated with HS. We suggest the implementation standard public dietary recommendations of Vitamin D supplementation, smoking cessation, and weight reduction behaviors with further assessment of disease course among HS patients.

Citing Articles

Plant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet.

Annunziata G, Verde L, Zink A, Muscogiuri G, Albanesi C, Paganelli A Curr Nutr Rep. 2025; 14(1):42.

PMID: 40048018 PMC: 11885338. DOI: 10.1007/s13668-025-00632-5.


To what Extent does Vitamin D and its Serum Levels Influence the Severity of Hidradenitis Suppurativa: A Literature Review.

Lackner L, Zyriax B, Stephan B Acta Derm Venereol. 2024; 104:adv40321.

PMID: 39254290 PMC: 11407108. DOI: 10.2340/actadv.v104.40321.


New-Onset Hidradenitis Suppurativa in Psoriasis Patients: A Multi-Center, Retrospective Cohort Study.

Li C, Lo S, Tsai R, Chang H, Gau S Life (Basel). 2024; 14(6).

PMID: 38929713 PMC: 11205059. DOI: 10.3390/life14060730.


Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management.

Yan A, Gallardo M, Savu A, Kaffenberger B Arch Dermatol Res. 2024; 316(7):397.

PMID: 38878169 PMC: 11180001. DOI: 10.1007/s00403-024-03125-7.


Vitamin D and wound healing: Assessing skin barrier function and implications for chloasma treatment.

Chen Q, Liu L, Zhang Y Int Wound J. 2024; 21(1):e14541.

PMID: 38272820 PMC: 10789544. DOI: 10.1111/iwj.14541.


References
1.
Kechichian E, Ezzedine K . Vitamin D and the Skin: An Update for Dermatologists. Am J Clin Dermatol. 2017; 19(2):223-235. DOI: 10.1007/s40257-017-0323-8. View

2.
Antal A, Dombrowski Y, Koglin S, Ruzicka T, Schauber J . Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression. Dermatoendocrinol. 2011; 3(1):18-22. PMC: 3051848. DOI: 10.4161/derm.3.1.14616. View

3.
Balgobind A, Finelt N, Strunk A, Garg A . Association between obesity and hidradenitis suppurativa among children and adolescents: A population-based analysis in the United States. J Am Acad Dermatol. 2019; 82(2):502-504. DOI: 10.1016/j.jaad.2019.08.034. View

4.
Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

5.
Jemec G, Heidenheim M, Nielsen N . The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996; 35(2 Pt 1):191-4. DOI: 10.1016/s0190-9622(96)90321-7. View